Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS
· Delayed Price · Currency is USD
0.2789
+0.0289 (11.56%)
Jun 23, 2025, 3:13 PM EDT
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $346.53 thousand as of June 24, 2025. Its market cap has decreased by -57.91% in one year.
Market Cap
346.53K
Enterprise Value
-1.17M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.28
Market Cap Chart
Since February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from 32.29M to 346.53K, a decrease of -98.93%. That is a compound annual growth rate of -64.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 310.63K | -83.27% |
| Dec 31, 2024 | 1.86M | -50.48% |
| Dec 29, 2023 | 3.75M | -48.56% |
| Dec 30, 2022 | 7.29M | -81.86% |
| Dec 31, 2021 | 40.18M | 24.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.59B |
| Elite Pharmaceuticals | 801.20M |
| Veradigm | 764.23M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 637.25M |
| American Oncology Network | 446.28M |
| CytoDyn | 386.66M |
| Glass House Brands | 378.93M |